Chief Regulatory and Development Officer
Newton BiocapitalCheck size: Newton Biocapital does not publish a standard current check-size range on its official site.
Michihiko Wada is listed in a Chief Regulatory and Development Officer capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Strong science, experienced teams and differentiated healthcare products with credible development and internationalization paths.
Opportunities outside life sciences or without evidence of unmet need, differentiation and development feasibility are less aligned.
Present the unmet need, evidence, intellectual property, regulatory and clinical plan, team and Europe-Japan opportunity.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Michihiko Wada is a current Chief Regulatory and Development Officer at Newton Biocapital, according to the firm's official roster. No additional background is inferred where the firm does not publish a biography.